Orthocell appointed Surgical Specialties as exclusive distributor in Australia and New Zealand for Ortho-ATI® (Autologous Tenocyte Injection) and Ortho-ACI® (Autologous Chondrocyte Implantation) cell therapies for tendon and cartilage regeneration, respectively. The five-year agreement allows Orthocell to focus resources on product development and regulatory approvals.
As noted by Phil Nicholl, CEO of Surgical Specialties, Orthocell has the only cell therapy interventions listed on the Australian Register of Therapeutic Goods for cartilage repair in knee and ankle joints. In other applications, Orthocell recently announced patient recruitment in a clinical trial of Ortho-ATI vs. corticosteroid injection to treat rotator cuff tendinopathy.
Sources: Orthocell; ORTHOWORLD Inc.
Orthocell appointed Surgical Specialties as exclusive distributor in Australia and New Zealand for Ortho-ATI® (Autologous Tenocyte Injection) and Ortho-ACI® (Autologous Chondrocyte Implantation) cell therapies for tendon and cartilage regeneration, respectively. The five-year agreement allows Orthocell to focus resources...
Orthocell appointed Surgical Specialties as exclusive distributor in Australia and New Zealand for Ortho-ATI® (Autologous Tenocyte Injection) and Ortho-ACI® (Autologous Chondrocyte Implantation) cell therapies for tendon and cartilage regeneration, respectively. The five-year agreement allows Orthocell to focus resources on product development and regulatory approvals.
As noted by Phil Nicholl, CEO of Surgical Specialties, Orthocell has the only cell therapy interventions listed on the Australian Register of Therapeutic Goods for cartilage repair in knee and ankle joints. In other applications, Orthocell recently announced patient recruitment in a clinical trial of Ortho-ATI vs. corticosteroid injection to treat rotator cuff tendinopathy.
Sources: Orthocell; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.